EEG dominant frequency as a potential biomarker of cognition in Lewy body diseases.
Objective: To determine whether cognitive performance correlates with posterior dominant frequency across Lewy body diseases. Background: DLB and PDD are associated with prominent posterior slow-wave…SARS-CoV-2 induced neurodegeneration in oxidative stress and genetic models of Parkinson’s Disease
Objective: Given similarities in systemic responses after infection with SARS-CoV-2 to those reported after the 1918 pandemic, we investigated whether SARS-CoV-2 could elicit a similar…Parkinson Disease. An innovative Aproach
Objective: Aims: promoting maximum autonomy, potentiating resources, improve functionality, stimulating activity, preventing complications. Background: Since 2006, the Program has operated uninterruptedly, even during COVID-19. Aimed…Immunomodulatory Effects Of Covid-19 Vaccination On Inflammatory And Neurotrophic Factors In Parkinson’s Disease: Insights From Clinical Subtypes
Objective: This study investigates the impact of COVID-19 vaccination on levels of interleukin 6 (IL-6) and brain-derived neurotrophic factor (BDNF) in patients with Parkinson's disease…Coat test: a bedside timed test for quantifying motor function in Parkinson’s disease patients.
Objective: To develop a bedside quantitative test for evaluating motor affectation in patients with Parkinson's Disease. Background: The MDS-UPDRS part III is still the most…Managing Cognitive Decline in Vascular Dementia with Associated Parkinsonism
Objective: The intersection of vascular dementia (VaD) and secondary parkinsonism presents a complex therapeutic conundrum, particularly in geriatric populations. This study aims to elucidate the…Subthalamic Nucleus Stimulation Modulates Cognitive Theory of Mind in Parkinson’s Disease
Objective: This study aims to investigate the effect of subthalamic nucleus (STN) deep brain stimulation (DBS) on ToM using the Parkinson’s disease (PD) model. Background:…Frontal dysfunction as a cognitive biomarker in prodromal Parkinson’s disease
Objective: To assess specific cognitive biomarkers to increase the sensibility for the diagnosis of Prodromal Parkinson’s disease (pPD) that could help to identify these patients.…Neuropsychological Predictors of Cognitive Decline in Parkinson’s Disease: A Systematic Review (PDCogniCare)
Objective: This systematic review aimed to synthesise current neuropsychological predictors of cognitive decline in Parkinson's disease (PD). Background: The observed heterogeneity of cognitive function in…Dual Frequency Stimulation of the Subthalamic Nucleus Improves Emotional State in Parkinson’s Disease
Objective: To evaluate the effect on emotional states of dual frequency STN-DBS (high frequency + low frequency) as compared to high frequency or low frequency…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.